<DOC>
	<DOCNO>NCT00972569</DOCNO>
	<brief_summary>The purpose study determine low dos BNP improve renal function people chronic heart failure renal dysfunction , also determine whether Sildenafil assist improvement . This study enroll hospitalized patient heart failure .</brief_summary>
	<brief_title>Low Dose Intravenous ( IV ) Infusion BNP Presence Absence Acute Type V Phosphodiesterase ( PDE V ) Improving Renal Function Hospitalized Chronic Heart Failure ( CHF ) Patients With Renal Dysfunction</brief_title>
	<detailed_description>The broad objective protocol advance understanding pathophysiological mechanism human Cardiorenal Syndrome ( CRS ) specific emphasis upon biological interaction diuretic therapy , renin-angiotensin-aldosterone-system ( RAAS ) cyclic 3'-5'-guanosine monophosphate ( cGMP ) pathway . Chronic heart failure ( CHF ) result leave ventricular systolic dysfunction clinical syndrome high mortality morbidity . Renal dysfunction common progressive complication CHF despite grow recognition frequent presentation combine cardiac renal dysfunction , `` Cardiorenal Syndrome ( CRS ) '' , underlie pathophysiology well understood , lack consensus appropriate management . The main objective study extend finding applicant 's study human experimental CHF determine low dose intravenous ( IV ) ( 0.005/Kg/min ) administration BNP hospitalize decompensated CHF patient renal dysfunction would improve renal function . Furthermore , base preliminary data , also seek assess PDE V inhibition potentiate renal enhancing action . Hypothesis : Low dose IV infusion BNP hospitalize decompensated CHF patient CRS enhance renal humoral function compare standard therapy , potentiate PDEV inhibition evident : Increased sodium excretion , Increased creatinine clearance Decreased plasma creatinine blood urea nitrogen Suppression renin-angiotensin-aldosterone system , Increased renal cGMP generation</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Natriuretic Peptide , Brain</mesh_term>
	<criteria>Patients admit St Mary 's Hospital , Mayo Clinic Rochester MN NYHA class IIIIV decompensated CHF renal dysfunction Calculated creatinine clearance equal le 60 ml/min great 20 ml/min use CockcroftGault formula . Cause acute renal dysfunction reasonably ascribe factor heart failure treatment Known intrinsic renal disease renal artery stenosis = &gt; 50 % Patients take Nitrates within previous 24 hour Patients need emergency coronary revascularization may rapidly change cardiac function ( i.e . patient acute myocardial infarction shock ) Peritoneal hemodialysis within 90 day anticipation dialysis ultrafiltration form require study period Systolic blood pressure &lt; 90 mmHg cardiogenic shock . Requirement pressor maintenance blood pressure . Intraaortic blood pump use . History significant uncorrected renal artery stenosis define &gt; 50 % stenosis . Severe aortic mitral stenosis significant LV outflow tract obstruction . Hgb &lt; 10 mg/dL Pregnant nursing woman . Contraindication nesiritide . Inability NSAID dose hold 30 hour , treat medication . Administration radiocontrast medium within 7 day enrollment anticipate use agent study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>BNP without PDE-V heart failure</keyword>
</DOC>